Mimi L. Quan
Hebei Medical University(CN)China University of Petroleum, Beijing(CN)Northeastern University(CN)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Atrial Fibrillation Management and Outcomes, Protease and Inhibitor Mechanisms, Vitamin K Research Studies
Most-Cited Works
- → Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor(2004)188 cited
- → Constrictive binding of large guests by a hemicarcerand containing four portals(1991)186 cited
- → Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa(2001)172 cited
- → Inhibition of Factor XIa as a New Approach to Anticoagulation(2010)95 cited
- → Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1(1999)80 cited
- → Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2